Browsing Tag
Oppenheimer
9 posts
Ondas Inc. (Nasdaq: ONDS) targets $525m in 2026 revenue as DZYNE share overhang weighs on the stock
Ondas Inc. has raised its 2026 revenue target to at least $525 million after closing the $875.8 million DZYNE Technologies acquisition and folding it into a new Ondas Sentinel defence division, but the shares have fallen from a June 2026 high near $9.40 into the mid-$6 range as investors work through a 40 million-share resale registration, a further 45 million shares of deferred consideration due in January 2027 and the integration burden of an unusually acquisition-heavy growth model. The next measurable checkpoint is the second-quarter 2026 earnings report expected in mid-August.
Almonty Industries (ALM) jumps 11% as DA Davidson lifts PT to $33 on tungsten thesis
Almonty (ALM) jumps 11% to $16.31 as DA Davidson lifts PT to $33 on record tungsten pricing; Sangdong ramp meets 2027 US defense mandate cliff head-on.
Chemomab Therapeutics (CMMB) and Scipher Medicine to merge in $150m reverse deal
Scipher Medicine and Chemomab are merging in all-stock deal, taking Scipher public via reverse merger. $30M PIPE led by Northpond. Q4 2026 close, H1 2028 Phase 2 data.
TeraWulf (NASDAQ: WULF) HPC pivot meets execution test as Lake Mariner ramps
TeraWulf (NASDAQ: WULF) signed USD 13B of AI hosting backlog with Google in the deal. The real test is whether Lake Mariner delivers on time.
MongoDB (MDB) jumps 20% on a beat-and-raise as AI workloads reaccelerate its cloud database growth
MongoDB jumped 20% after a Q1 beat-and-raise, with revenue up 25%, backlog up 88%, and AI workloads moving into production. Analysts rushed to lift price targets.
Sensata Technologies downgraded to equal weight by Barclays after ST nearly doubles in a year
Barclays cut Sensata Technologies to equal weight after ST nearly doubled in a year, even as it raised the target to $53. The turnaround now looks priced in.
GEV stock near all-time high as GE Vernova reports $18.3bn in Q1 orders and lifts full-year outlook
GE Vernova (NYSE: GEV) raises 2026 guidance after Q1 orders of $18.3B, $163B backlog, and record free cash flow. Read the full executive analysis.
Cinemark crushes summer box office records: Find out how
Cinemark Holdings, Inc., a significant player in the global movie theater industry, reported that the weekend of July…
Sacred or profane? Oppenheimer faces backlash over Bhagavad Gita scene
The latest film by Christopher Nolan, “Oppenheimer,” has stirred up controversy over a scene where the protagonist, J.…